Director Seamus Mulligan receives 1,605 RSUs at Jazz Pharmaceuticals (JAZZ)
Rhea-AI Filing Summary
Mulligan Seamus reported acquisition or exercise transactions in this Form 4 filing.
Jazz Pharmaceuticals director Seamus Mulligan received an equity award covering 1,605 ordinary shares through restricted stock units under the 2007 Amended and Restated Non-Employee Directors Stock Award Plan. The units vest in full on July 23, 2027, subject to continuous service and conditions. After this award he holds 1,184,633 ordinary shares directly, plus 101,621 shares indirectly through Nerano Pharma Limited, an entity owned and controlled by him and his immediate family.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 1,605 shares
Net Buy
2 txns
Insider
Mulligan Seamus
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Ordinary Shares F1 | 1,605 | $0.00 | $0.00 |
| holding | Ordinary Shares F2 | -- | -- | -- |
Holdings After Transaction:
Ordinary Shares — 1,184,633 shares (Direct);
Ordinary Shares — 101,621 shares (Indirect, By Nerano Pharma Lim)
Footnotes (2)
- F1. These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027.
- F2. Shares beneficially owned by Nerano Pharma Limited, an entity owned and controlled by the reporting person and his immediate family.
Key Figures
Restricted stock units granted: 1,605 shares
Direct ordinary shares after award: 1,184,633 shares
Indirect ordinary shares held: 101,621 shares
+1 more
4 metrics
Restricted stock units granted
1,605 shares
Equity award to director Seamus Mulligan on 2026-08-05
Direct ordinary shares after award
1,184,633 shares
Direct holdings of Seamus Mulligan following RSU grant
Indirect ordinary shares held
101,621 shares
Indirect holdings through Nerano Pharma Limited
RSU vesting date
July 23, 2027
Date when 1,605 restricted stock units vest in full
Key Terms
restricted stock units, beneficially owned, Non-Employee Directors Stock Award Plan
3 terms
restricted stock units financial
"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
beneficially owned financial
"Shares beneficially owned by Nerano Pharma Limited, an entity owned and controlled by the reporting person and his immediate family."
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Non-Employee Directors Stock Award Plan financial
"Granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan."
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity award did Seamus Mulligan receive at Jazz Pharmaceuticals (JAZZ)?
Seamus Mulligan received 1,605 restricted stock units, each representing one ordinary share. The grant was made under Jazz Pharmaceuticals’ 2007 Amended and Restated Non-Employee Directors Stock Award Plan as part of his compensation as a non-employee director.
When do Seamus Mulligan’s new RSUs in Jazz Pharmaceuticals (JAZZ) vest?
The 1,605 restricted stock units vest in full on July 23, 2027. Vesting is contingent on Mulligan’s continuous service as a director and satisfaction of certain additional conditions specified in the stock award plan.
What indirect holdings in Jazz Pharmaceuticals (JAZZ) are attributed to Seamus Mulligan?
In addition to his direct stake, 101,621 ordinary shares are beneficially owned by Nerano Pharma Limited, an entity owned and controlled by Mulligan and his immediate family, and reported as his indirect holdings in Jazz Pharmaceuticals.